Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model

By Abe Y.   Kasuya H.   Suzuki S.   Yamanishi Y.   Hori T.  

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation

By Lee L.-W.   Peng H.-C.   Ko W.-C.   Hung W.-C.   Su C.-H.   Lin C.-H.   Huang T.-F.   Yen M.-H.   Sheu J.-R.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite

Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite